[1] |
Fausto N, Campbell JS, Riehle KJ. Liver regeneration[J]. J Hepatol, 2012, 57(3):692-694.
|
[2] |
Koniaris LG, McKillop IH, Schwartz SI, et al. Liver regeneration[J]. J Am Coll Surg, 2003, 197(4):634-659.
|
[3] |
Fausto N, Campbell JS, Riehle KJ. Liver regeneration[J]. Hepatology, 2006, 43(2 Suppl 1):S45-S53.
|
[4] |
刘允怡,刘晓欣.对"联合肝脏离断和门静脉结扎的二步肝切除术"的述评[J].中华消化外科杂志,2013, 12(7):481-484.
|
[5] |
Gruttadauria S, Vasta F, Minervini MI, et al. Significance of the effective remnant liver volume in major hepatectomies[J]. Am Surg, 2005, 71(3):235-240.
|
[6] |
De Santibañes E, Clavien PA. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach[J]. Ann Surg, 2012, 255(3):415-417.
|
[7] |
Clavien PA, Petrowsky H, DeOliveira ML, et al. Strategies for safer liver surgery and partial liver transplantation[J]. N Engl J Med, 2007, 356(15):1545-1559.
|
[8] |
Kianmanesh R, Farges O, Abdalla EK, et al. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases[J]. J Am Coll Surg, 2003, 197(1):164-170.
|
[9] |
Nadalin S, Capobianco I, Li J, et al. Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): lessons learned from 15 cases at a single centre[J]. Z Gastroenterol, 2014, 52(1):35-42.
|
[10] |
Gauzolino R, Blanleuil ML. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion: an extension of the ALPPS approach[J]. Eur J Surg Oncol, 2014, 40(1):128.
|
[11] |
Tschuor Ch, Croome KP, Sergeant G, et al. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion: an extension of the ALPPS approach[J]. Eur J Surg Oncol, 2013, 39(11):1230-1235.
|
[12] |
Torres OJ, Fernandes Ede S, Oliveira CV, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): the Brazilian experience[J]. Arq Bras Cir Dig, 2013, 26(1):40-43.
|
[13] |
Oldhafer KJ, Donati M, Jenner RM, et al. ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence[J]. World J Surg, 2014, 38(6):1504-1509.
|
[14] |
Hahn O, Dudás I, Pajor P, et al. ALPPS (Associated Liver Partition and Portal vein ligation for Staged hepatectomy) : faster and greater growth of liver[J]. Magy Seb, 2013, 66(1):21-26.
|
[15] |
Li J, Girotti P, Königsrainer I, et al. ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?[J]. J Gastrointest Surg, 2013, 17(5):956-961.
|
[16] |
Govil S. Rapid improvement in liver volume induced by portal vein ligation and staged hepatectomy: the ALPPS procedure[J]. HPB, 2012, 14(12):874.
|
[17] |
Ratti F, Cipriani F, Gagliano A, et al. Defining indications to ALPPS procedure: technical aspects and open issues[J]. Updates Surg, 2014, 66(1):41-49.
|
[18] |
Vennarecci G, Laurenzi A, Santoro R, et al. The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion[J]. World J Surg, 2014, 38(6):1498-1503.
|
[19] |
Torres OJ, Moraes-Junior JM, Lima e Lima NC, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new approach in liver resections[J]. Arq Bras Cir Dig, 2012, 25(4):290-292.
|
[20] |
Alvarez FA, Ardiles V, Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks[J]. J Gastrointest Surg, 2013, 17(4):814-821.
|
[21] |
吕璟.肝再生相关细胞因子的探究[J].解剖科学进展,2005, 11(2):174-179.
|
[22] |
苏丽娟,阴正兴,王文博,等.调控肝再生的胞内信号通路研究进展[J].国际遗传学杂志,2008, 31(5):351-355.
|
[23] |
杨华,戴朝六.门静脉栓塞后肝再生机制研究进展[J].中国实用外科杂志,2013, 33(12):1068-1070.
|
[24] |
Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases[J]. Arch Surg, 2008, 143(10):978-982.
|
[25] |
Fuke H, Saitou Y, Nakano T, et al. Matrix metalloproteinase, hepatocyte growth factor, and tissue inhibitor of matrix metalloproteinase during human liver regeneration[J]. Liver Int, 2006, 26(3):380-381.
|
[26] |
Padrissa-Altés S, Zaouali MA, Franco-Gou R, et al. Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix[J]. Am J Transplant, 2010, 10(5):1167-1177.
|
[27] |
Bellayr IH, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments[J]. Future Med Chem, 2009, 1(6):1095-1111.
|